Kusha
Active Director Director DIN 00181253
DIN 00181253 First appointment Feb 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2001
Shareholding value •••• Premium profile

About Kusha

Data last updated:

Kusha is a Director at Das Drugs Private Limited (since 2025) and Director at Kant Drugs Private Limited (since 2001). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹49.46 Cr; the largest is Das Drugs Private Limited at ₹38.25 Cr (FY 2025).

DIN 00181253
Primary Designation Director
Industry Pharma
First Appointment 05 Feb 2001
Oldest Company Age 29 yrs
Largest company Das Drugs Private Limited · ₹38.25 Cr (FY 2025)
Combined revenue ₹49.46 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Das Drugs Private Limited U51109UP1997PTC022083
Director17 Dec 20251997₹38.25 Cr (FY 2025)Active
Kant Drugs Private Limited U24232UP2001PTC025855
Director05 Feb 20012001₹11.20 Cr (FY 2022)Active

Directorship timeline

Open interactive timeline →
Kant Drugs Private Limited
Das Drugs Private Limited
Premium access

Shareholding and investment profile for Kusha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kusha

Kusha currently holds 2 directorships: Das Drugs Private Limited (Director, since 17 Dec 2025, revenue ₹38.25 Cr (FY 2025)); Kant Drugs Private Limited (Director, since 05 Feb 2001, revenue ₹11.20 Cr (FY 2022)).

Kusha was first appointed on 05 Feb 2001 as Director at Kant Drugs Private Limited. The most recent appointment on record is 17 Dec 2025 at Das Drugs Private Limited.

The 2 current companies of Kusha that report revenue have a combined latest revenue of ₹49.46 Cr: Das Drugs Private Limited ₹38.25 Cr (FY 2025); Kant Drugs Private Limited ₹11.20 Cr (FY 2022).

The current boards of Kusha's companies include Anupama Rastogi (Das Drugs Private Limited), Anurag Das (Das Drugs Private Limited), Aruna Das (Das Drugs Private Limited), Ashwiti Das (Das Drugs Private Limited), Bharati Patwari Rastogi (Das Drugs Private Limited), Manjulata Rastogi (Das Drugs Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available